首页> 外国专利> Optimization of serum potassium therapy for hemotherapy of renal failure, especially home hemodialysis

Optimization of serum potassium therapy for hemotherapy of renal failure, especially home hemodialysis

机译:血清钾疗法在肾衰竭,尤其是家庭血液透析的血液疗法中的优化

摘要

A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.
机译:一种在血液透析期间预测患者血清钾浓度的方法,包括在血液透析治疗期间测量患者的血清钾浓度以及通过初始血液透析期间患者的透析前和透析后体重之间的差计算的超滤率。疗程除以该疗程的总治疗时间,并估算出患者的钾动员清除率和透析前的钾分布量。然后,可以在任何血液透析治疗期间的任何时间,通过估计的钾动员清除率和透析前患者的钾分布量来预测患者的血清钾浓度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号